Ashwagandha — Expert Claims
Extracted from publicly available podcast transcripts and videos. Each claim is attributed and sourced.
Expert Consensus
Dose divergence: Experts recommend different amounts (300–600milligrams, 300-600milligrams, 600milligrams). Check the Stack & Timing tab for study-backed dosing ranges.
Claims are extracted using AI (Claude) from publicly available transcripts, each attributed to its source with an extraction-confidence rating (high / medium / low) so it can be verified, then compared against PubMed research. See how our data is made.
356 expert mentions
“I generally recommend cycling it — I'll take it for 8 to 12 weeks, then take a few weeks off.”
Huberman recommends cycling ashwagandha — taking it for 8 to 12 weeks, then taking a few weeks off.
None of the 10 published studies provided contain key findings, population details, or limitations data that would allow a direct evaluation of Huberman's cycling recommendation (8–12 weeks on, then a…
“I generally recommend cycling it — I'll take it for 8 to 12 weeks, then take a few weeks off.”
Huberman recommends cycling ashwagandha — taking it for 8 to 12 weeks, then taking a few weeks off.
None of the 10 listed studies contain extractable key findings, populations, or limitations data, making direct comparison impossible. More critically, none of the studies appear to specifically inves…
“actively managing your stress is important and not with drugs but things like adaptogens riola ashwagandha Jin sing Siberian Jin sing all can be helpful”
Ashwagandha, as an adaptogen, can be helpful for actively managing stress.
Multiple RCTs and a meta-analysis (PMID 36017529) support ashwagandha's beneficial effect on stress and anxiety, with individual RCTs (PMIDs 31517876, 37740662, 35984870) demonstrating stress-relievin…
“I generally recommend cycling it — I'll take it for 8 to 12 weeks, then take a few weeks off.”
Huberman recommends cycling ashwagandha — taking it for 8 to 12 weeks, then taking a few weeks off.
None of the 10 published studies provided contain extractable key findings, populations, or limitations data, making direct evidence-based comparison impossible. The available RCTs (PMIDs 31517876, 37…
“I generally recommend cycling it — I'll take it for 8 to 12 weeks, then take a few weeks off.”
Huberman recommends cycling ashwagandha — taking it for 8 to 12 weeks, then taking a few weeks off.
None of the 10 published studies provided contain key findings, population details, or limitations data that would allow meaningful evaluation of Huberman's cycling recommendation (8–12 weeks on, then…
“I generally recommend cycling it — I'll take it for 8 to 12 weeks, then take a few weeks off.”
Huberman recommends cycling ashwagandha — taking it for 8 to 12 weeks, then taking a few weeks off.
None of the 10 published studies provided contain key findings, population details, or limitations data that would allow a direct comparison to Huberman's cycling recommendation. The available RCTs an…
“I generally recommend cycling it — I'll take it for 8 to 12 weeks, then take a few weeks off.”
Huberman recommends cycling ashwagandha — taking it for 8 to 12 weeks, then taking a few weeks off.
None of the published studies provided in the reference list directly evaluate a cycling protocol for ashwagandha (i.e., 8–12 weeks on followed by a break). The RCTs and systematic reviews listed (e.g…
“actively managing your stress is important and not with drugs but things like adaptogens riola ashwagandha Jin sing Siberian Jin sing all can be helpful”
Ashwagandha, as an adaptogen, can be helpful for actively managing stress.
Multiple RCTs (e.g., PMID 31517876, a 60-day double-blind placebo-controlled study, and PMID 37740662, a 12-week RCT in overweight adults with self-reported stress) demonstrate statistically significa…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The expert's claim references a specific 2012 study by Chandrasekhar et al. examining serum cortisol reduction with ashwagandha. None of the 10 studies provided in the research list correspond to this…
“there are a handful of studies showing that ashwagandha supplementation increases testosterone levels — roughly an 11 to 17% increase over placebo in some trials”
Studies show ashwagandha supplementation increases testosterone levels in men by roughly 11 to 17% over placebo.
The provided research abstracts contain no extractable key findings, populations, or limitations — all relevant fields are null or incomplete. While the literature set includes a systematic review on…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses used in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, taken split or once daily for 8 to 12 weeks.
The published research list includes multiple RCTs (PMIDs 31517876, 37740662, 35984870), a meta-analysis (PMID 36017529), and clinical guidelines (PMID 35311615) that are directly relevant to ashwagan…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied.”
The two most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril.
The provided research abstracts contain no key findings, population details, or limitations data that directly address which ashwagandha extracts are most commonly studied in clinical trials. While th…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided literature includes relevant study types — including RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) — that are consistent with the general scientific conver…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim that ashwagandha is the 'most clinically studied adaptogen' is a comparative assertion requiring head-to-head bibliometric data across all adaptogens (e.g., Rhodiola rosea, Panax ginseng, El…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7 in ashwagandha trials.
The available literature includes a meta-analysis (PMID: 36017529) and at least one RCT (PMID: 31517876) that are directly relevant to ashwagandha's effects on stress and anxiety, and the general dire…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed approximately a 27% reduction in serum cortisol with ashwagandha.
The expert's claim specifically references the Chandrasekhar et al. 2012 RCT and cites a precise 27% reduction in serum cortisol with ashwagandha. While that study is a well-known published RCT, it do…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Ashwagandha improved subjective measures of stress and anxiety on validated scales including the PSS and the GAD-7 in clinical trials.
The available evidence base includes a meta-analysis (PMID: 36017529), multiple RCTs (PMIDs: 31517876, 37740662, 35984870), and a WFSBP/CANMAT clinical guideline (PMID: 35311615), all of which are rel…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick believes the cortisol-reducing and stress/anxiety effects of ashwagandha are real, with meaningful effect sizes, replication, and a biologically plausible mechanism.
The available literature includes a meta-analysis (PMID 36017529, rated strong quality) and multiple RCTs (PMIDs 31517876, 37740662, 35984870) that appear directly relevant to ashwagandha's effects on…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population.”
A handful of trials show modest testosterone increases in men of approximately 10 to 17% with ashwagandha, but these studies are small and mostly conducted in infertile or sub-fertile men, limiting generalizability.
The systematic review on herbs and testosterone (PMID: 33150931) is the most directly relevant study in the provided list and would be expected to address ashwagandha's effects on testosterone in men,…
“the standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day”
The standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day.
The provided research abstracts contain no extractable key findings, populations, or limitations — the metadata fields are uniformly null or empty. While several relevant study types are present (RCTs…
“A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.”
A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.
None of the 10 provided studies directly examine ashwagandha's effects on muscle size or strength in resistance-trained men. The retrieved literature focuses on stress, anxiety, cognition, testosteron…
“The specific extracts that have the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.”
The specific ashwagandha extracts with the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.
The expert claims that KSM-66 and Sensoril are the most researched standardized ashwagandha root extracts. While the provided research list includes several RCTs, systematic reviews, and meta-analyses…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim that ashwagandha is 'the most clinically studied adaptogen' is a comparative assertion requiring head-to-head data on clinical trial volume across multiple adaptogens (e.g., Panax ginseng, R…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.
The published research includes multiple RCTs (PMIDs 31517876, 37740662, 35984870), a meta-analysis (PMID 36017529), and WFSBP/CANMAT clinical guidelines (PMID 35311615) that are consistent with ashwa…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The expert specifically cites a 2012 Chandrasekhar et al. study with a ~27% cortisol reduction, but that study does not appear by name or PMID in the provided research list. While the list includes se…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick considers the cortisol and stress/anxiety reduction effects of ashwagandha to be real, with meaningful effect sizes, replication, and biological plausibility.
The available literature includes a meta-analysis (PMID: 36017529, rated strong quality) and at least one double-blind RCT (PMID: 31517876) that appear to examine ashwagandha's effects on anxiety and…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population. I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
A handful of small trials show modest testosterone increases of 10 to 17% in men with ashwagandha, but most were conducted in infertile or sub-fertile men and are not generalizable to healthy men with normal baseline testosterone.
The provided research corpus does not contain the specific RCTs examining ashwagandha's effect on testosterone in infertile or sub-fertile men that would be needed to directly evaluate Patrick's claim…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied. These are important distinctions because withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
The most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril, and these are important distinctions because withanolide content varies enormously across raw ashwagandha products.
The provided research abstracts contain no extractable key findings, populations, or limitations — the metadata fields are uniformly empty — making it impossible to directly verify or contradict the c…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The available research list includes relevant study types — including RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) — that are consistent with investigating cortisol an…
“There are multiple double-blind placebo-controlled trials showing that KSM-66 supplementation at doses of 300 to 600 milligrams per day significantly reduces serum cortisol levels and reduces subjective measures of stress and anxiety.”
Multiple double-blind placebo-controlled trials show that KSM-66 at 300 to 600 milligrams per day significantly reduces serum cortisol levels and subjective measures of stress and anxiety.
The available research base includes at least one double-blind, placebo-controlled RCT (PMID: 31517876) and a meta-analysis of RCTs (PMID: 36017529) that are consistent with the general claim that ash…
“One of the most cited studies showed a 27% reduction in cortisol in the supplementation group versus placebo over 60 days.”
One of the most cited studies showed a 27% reduction in cortisol in the KSM-66 supplementation group versus placebo over 60 days.
The expert's claim references a specific 27% cortisol reduction finding from a KSM-66 RCT over 60 days, which appears to align with a known published trial (Chandrasekhar et al. or similar KSM-66 bran…
“there's some evidence that ashwagandha has mild sedative properties that make it slightly more useful taken in the evening”
There is some evidence that ashwagandha has mild sedative properties that make it slightly more useful when taken in the evening.
The provided research abstracts contain no extractable key findings, populations, or limitations — all relevant fields are null — making it impossible to directly verify or contradict Huberman's claim…
“There's also reasonable evidence for muscle recovery and strength, independent of the testosterone effects.”
There is reasonable evidence for ashwagandha improving muscle recovery and strength, independent of its testosterone effects.
The 10 provided studies do not include any research specifically examining ashwagandha's effects on muscle recovery or strength independent of testosterone. The available studies focus primarily on st…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim that ashwagandha is 'the most clinically studied adaptogen' is a comparative assertion requiring head-to-head evidence against other adaptogens (e.g., Rhodiola rosea, Panax ginseng, Eleuther…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed approximately a 27% reduction in serum cortisol with ashwagandha.
The expert references the Chandrasekhar et al. 2012 RCT specifically, claiming approximately 27% reduction in serum cortisol with ashwagandha. However, that specific study does not appear in the provi…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The available research corpus includes relevant study types — including RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) — that are consistent with the general claim that…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
While the retrieved literature includes relevant study types (meta-analyses, RCTs, and systematic reviews on ashwagandha), none of the provided records include extractable key findings, population det…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim that ashwagandha is 'the most clinically studied adaptogen' is a comparative assertion requiring head-to-head bibliometric data across multiple adaptogenic herbs (e.g., Rhodiola rosea, Panax…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick considers the cortisol and stress/anxiety reduction effects of ashwagandha to be real, with meaningful effect sizes, replication, and biological plausibility.
The available literature includes a meta-analysis (PMID 36017529, rated strong quality) and multiple RCTs (PMIDs 31517876, 37740662, 35984870) that appear to address ashwagandha's effects on stress an…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Ashwagandha improved subjective measures of stress and anxiety on validated scales including the PSS and the GAD-7 in clinical trials.
The available literature includes a meta-analysis (PMID 36017529), multiple RCTs (PMIDs 31517876, 37740662, 35984870), and a WFSBP/CANMAT clinical guideline taskforce paper (PMID 35311615), all of whi…
“there's some evidence that ashwagandha has mild sedative properties that make it slightly more useful taken in the evening”
There is some evidence that ashwagandha has mild sedative properties that make it slightly more useful when taken in the evening.
The provided research abstracts contain no extractable key findings, populations, or limitations — all relevant fields are null — making it impossible to directly evaluate Huberman's claim that ashwag…
“the standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day”
The standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day.
The provided research abstracts contain no extractable key findings, population data, or dosage information — all critical fields are listed as 'None.' While the studies listed (including RCTs with PM…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7 in ashwagandha trials.
The claim that ashwagandha improves subjective stress and anxiety on validated scales like the PSS and GAD-7 is biologically plausible and directionally consistent with the retrieved literature, which…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied.”
The two most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril.
The provided research abstracts contain no key findings, population data, or limitations that directly address which ashwagandha extracts are most commonly studied in clinical trials. While the litera…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The expert's claim specifically references the 2012 Chandrasekhar et al. study and a ~27% cortisol reduction figure. None of the provided research entries include this specific study or report its key…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population.”
A handful of trials show modest testosterone increases in men of approximately 10 to 17% with ashwagandha, but these studies are small and mostly conducted in infertile or sub-fertile men, limiting generalizability.
The systematic review on herbs and testosterone (PMID: 33150931) is the most directly relevant study in this set and aligns with the general claim that ashwagandha may influence testosterone in men, b…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population. I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
A handful of small trials show modest testosterone increases of 10 to 17% in men with ashwagandha, but most were conducted in infertile or sub-fertile men and are not generalizable to healthy men with normal baseline testosterone.
The provided research corpus does not contain the specific RCT or trial data needed to directly verify the claimed 10–17% testosterone increase figures or the characterization of study populations as…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses used in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, taken split or once daily for 8 to 12 weeks.
The research list includes RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) that study ashwagandha supplementation, which is broadly consistent with the claim that positiv…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick believes the cortisol-reducing and stress/anxiety effects of ashwagandha are real, with meaningful effect sizes, replication, and a biologically plausible mechanism.
The available literature includes a meta-analysis (PMID: 36017529, rated strong quality) and multiple RCTs (PMIDs: 31517876, 37740662, 35984870) that directly examine ashwagandha's effects on stress a…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.
The provided research corpus includes relevant RCTs (PMIDs 31517876, 37740662, 35984870), a meta-analysis (PMID 36017529), and clinical guidelines (PMID 35311615) that are consistent with the general…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied. These are important distinctions because withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
The most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril, and these are important distinctions because withanolide content varies enormously across raw ashwagandha products.
The provided research abstracts contain no key findings, population details, or limitations data, making it impossible to directly assess Dr. Patrick's specific claims about KSM-66 and Sensoril being…
“The specific extracts that have the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.”
The specific ashwagandha extracts with the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.
The claim that KSM-66 and Sensoril are among the most-researched standardized ashwagandha extracts is broadly consistent with the general scientific literature, and several of the listed studies (e.g.…
“One of the most cited studies showed a 27% reduction in cortisol in the supplementation group versus placebo over 60 days.”
One of the most cited studies showed a 27% reduction in cortisol in the KSM-66 supplementation group versus placebo over 60 days.
The expert claims a specific 27% cortisol reduction associated with KSM-66 ashwagandha over 60 days, citing a widely-referenced RCT. While the provided literature list includes relevant RCTs (PMIDs 31…
“There's also reasonable evidence for muscle recovery and strength, independent of the testosterone effects.”
There is reasonable evidence for ashwagandha improving muscle recovery and strength, independent of its testosterone effects.
The provided research database contains no studies directly examining ashwagandha's effects on muscle recovery or strength. The available studies focus on stress, anxiety, cognitive function, testoste…
“there are a handful of studies showing that ashwagandha supplementation increases testosterone levels — roughly an 11 to 17% increase over placebo in some trials”
Studies show ashwagandha supplementation increases testosterone levels in men by roughly 11 to 17% over placebo.
The provided research abstracts contain no extractable key findings, populations, or limitations — making it impossible to directly verify or refute Huberman's specific claim of an 11–17% testosterone…
“A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.”
A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.
None of the 10 retrieved studies directly address muscle size or strength outcomes in resistance-trained men. The available research focuses primarily on stress, anxiety, cognition, testosterone, and…
“There are multiple double-blind placebo-controlled trials showing that KSM-66 supplementation at doses of 300 to 600 milligrams per day significantly reduces serum cortisol levels and reduces subjective measures of stress and anxiety.”
Multiple double-blind placebo-controlled trials show that KSM-66 at 300 to 600 milligrams per day significantly reduces serum cortisol levels and subjective measures of stress and anxiety.
The available research includes relevant study types that align with Huberman's claim — notably a double-blind RCT (PMID: 31517876) examining stress-relieving effects of ashwagandha extract, a meta-an…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick considers the cortisol and stress/anxiety reduction effects of ashwagandha to be real, with meaningful effect sizes, replication, and biological plausibility.
Multiple RCTs in the provided list (e.g., PMIDs 31517876, 35984870) specifically examine ashwagandha's stress-relieving and anxiety-reducing effects, and a systematic review (PMID 38140274, rated stro…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The provided research includes 10 studies on ashwagandha (multiple RCTs and one systematic review), demonstrating that ashwagandha has a meaningful clinical trial base across outcomes like stress, sle…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Ashwagandha improved subjective measures of stress and anxiety on validated scales including the PSS and the GAD-7 in clinical trials.
Several RCTs in the provided list (e.g., PMID 31517876 — a randomized, double-blind, placebo-controlled study on stress-relieving actions of ashwagandha, and PMID 35984870 — a double-blind RCT on stre…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided literature includes multiple RCTs and a systematic review that are consistent with the general body of ashwagandha research on stress and cortisol (e.g., PMIDs 31517876, 37740662, 3814027…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick believes the cortisol-reducing and stress/anxiety effects of ashwagandha are real, with meaningful effect sizes, replication, and a biologically plausible mechanism.
The body of retrieved studies includes multiple RCTs (e.g., PMIDs 31517876, 35984870) and a systematic review (PMID 38140274) that are directly relevant to ashwagandha's stress, anxiety, and cortisol-…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The expert's claim references a specific 2012 study by Chandrasekhar et al. examining ashwagandha's effect on serum cortisol. None of the 10 studies provided in the research list correspond to this 20…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population.”
A handful of trials show modest testosterone increases in men of approximately 10 to 17% with ashwagandha, but these studies are small and mostly conducted in infertile or sub-fertile men, limiting generalizability.
None of the 10 retrieved studies directly address testosterone levels in men, infertile or otherwise. The provided research covers perimenopause symptoms in women, sleep quality, cardiorespiratory end…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied.”
The two most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril.
The provided PubMed abstracts do not contain sufficient detail (key findings, populations, or explicit extract identifications are largely absent) to directly confirm or deny which ashwagandha extract…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The provided research consists of 10 studies on ashwagandha (mostly moderate-quality RCTs and one strong systematic review), demonstrating that ashwagandha has a meaningful clinical research base acro…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Ashwagandha improved subjective measures of stress and anxiety on validated scales including the PSS and the GAD-7 in clinical trials.
The available literature includes multiple RCTs and a systematic review examining ashwagandha's effects on stress and anxiety, and the claim that validated scales such as the PSS and GAD-7 were used i…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The provided studies (10 RCTs and 1 systematic review) confirm that ashwagandha has a meaningful clinical trial base spanning stress, sleep, athletic performance, and perimenopause. However, the claim…
“There's also reasonable evidence for muscle recovery and strength, independent of the testosterone effects.”
There is reasonable evidence for ashwagandha improving muscle recovery and strength, independent of its testosterone effects.
The most directly relevant study in the provided list is PMID 26609282, an RCT specifically examining ashwagandha's effect on muscle strength and recovery, which aligns with the expert's claim. PMID 3…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick considers the cortisol and stress/anxiety reduction effects of ashwagandha to be real, with meaningful effect sizes, replication, and biological plausibility.
Multiple RCTs in the provided list (e.g., PMIDs 31517876, 35984870) specifically investigate ashwagandha's stress-relieving effects, and a systematic review (PMID 38140274, rated strong quality) is al…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied.”
The two most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril.
The claim that KSM-66 and Sensoril are the two most commonly studied standardized ashwagandha extracts in clinical trials is a bibliometric/meta-level observation about the research landscape, not a f…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The provided research includes 10 studies (9 RCTs and 1 systematic review) documenting various clinical trials on ashwagandha across stress, sleep, athletic performance, and perimenopausal symptoms. W…
“There are multiple double-blind placebo-controlled trials showing that KSM-66 supplementation at doses of 300 to 600 milligrams per day significantly reduces serum cortisol levels and reduces subjective measures of stress and anxiety.”
Multiple double-blind placebo-controlled trials show that KSM-66 at 300 to 600 milligrams per day significantly reduces serum cortisol levels and subjective measures of stress and anxiety.
The provided PubMed results include multiple double-blind, randomized, placebo-controlled trials on ashwagandha (Withania somnifera) extracts, including at least one study (PMID: 31517876) that appear…
“there's some evidence that ashwagandha has mild sedative properties that make it slightly more useful taken in the evening”
There is some evidence that ashwagandha has mild sedative properties that make it slightly more useful when taken in the evening.
Several RCTs in the provided list (PMIDs 32818573 and 32540634) specifically investigate ashwagandha's effects on sleep quality, lending plausibility to sedative or sleep-promoting properties. However…
“A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.”
A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.
PMID 26609282 is an RCT examining ashwagandha supplementation on muscle strength and recovery, which aligns most closely with Huberman's claim about resistance-trained men showing gains in muscle size…
“There's also reasonable evidence for muscle recovery and strength, independent of the testosterone effects.”
There is reasonable evidence for ashwagandha improving muscle recovery and strength, independent of its testosterone effects.
The most directly relevant study in the provided list is PMID 26609282, an RCT specifically examining ashwagandha's effect on muscle strength and recovery, which aligns with the expert's claim. PMID 3…
“The specific extracts that have the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.”
The specific ashwagandha extracts with the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.
The provided studies do include RCTs using ashwagandha root extracts, and several (e.g., PMIDs 26609282, 31517876, 32540634, 32818573, 33600918) are known in the literature to use KSM-66 or Sensoril f…
“the standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day”
The standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day.
The provided research abstracts lack key details (dosages, populations, sample sizes, and findings are all listed as 'None'), making it impossible to directly verify whether 300–600 mg/day of KSM-66 i…
“there are a handful of studies showing that ashwagandha supplementation increases testosterone levels — roughly an 11 to 17% increase over placebo in some trials”
Studies show ashwagandha supplementation increases testosterone levels in men by roughly 11 to 17% over placebo.
None of the 10 retrieved studies directly report testosterone outcomes in men, which is the specific claim being evaluated. The studies provided focus on perimenopause symptoms, sleep quality, stress…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The provided research includes 10 studies (9 RCTs and 1 systematic review) that document clinical investigations of ashwagandha across various outcomes such as stress, sleep, athletic performance, and…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick believes the cortisol-reducing and stress/anxiety effects of ashwagandha are real, with meaningful effect sizes, replication, and a biologically plausible mechanism.
Multiple RCTs in the provided list (e.g., PMIDs 31517876, 35984870) appear directly relevant to stress, anxiety, and cortisol outcomes, and a systematic review (PMID 38140274, rated strong quality) is…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.
The provided PubMed studies are all RCTs or systematic reviews of ashwagandha, which is consistent with the type of evidence Patrick references, and the study titles align with research areas (stress,…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided research list includes multiple RCTs and a systematic review that appear relevant to ashwagandha's effects on stress-related outcomes, including PMID 31517876 (a randomized, double-blind,…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The expert's claim specifically references the 2012 Chandrasekhar et al. RCT on ashwagandha and serum cortisol reduction. This study does not appear among the 10 provided PubMed records, and none of t…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed approximately a 27% reduction in serum cortisol with ashwagandha.
The expert's claim specifically references the 2012 Chandrasekhar et al. RCT and a ~27% cortisol reduction figure. None of the 10 studies provided in the research list correspond to or clearly identif…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.
The provided PubMed studies are consistent with ashwagandha RCTs that commonly use standardized root extracts in the 300–600 mg/day range over 8–12 week durations, which aligns with the expert's claim…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population. I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
A handful of small trials show modest testosterone increases of 10 to 17% in men with ashwagandha, but most were conducted in infertile or sub-fertile men and are not generalizable to healthy men with normal baseline testosterone.
None of the 10 retrieved studies directly address testosterone outcomes in men, infertile or otherwise. The studies provided focus on perimenopause symptoms, sleep quality, stress relief, cardiorespir…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied. These are important distinctions because withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
The most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril, and these are important distinctions because withanolide content varies enormously across raw ashwagandha products.
The provided studies do include RCTs and a systematic review using standardized ashwagandha extracts, and several PMIDs reference 'standardized' preparations in their titles, which is broadly consiste…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses used in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, taken split or once daily for 8 to 12 weeks.
The provided studies are all RCTs or systematic reviews examining ashwagandha supplementation across various outcomes (stress, sleep, athletic performance, perimenopause), which is consistent with the…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7 in ashwagandha trials.
The expert's claim that validated scales like the PSS (Perceived Stress Scale) and GAD-7 (Generalized Anxiety Disorder scale) showed improvement in ashwagandha trials is plausible and consistent with…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided studies include multiple RCTs (e.g., PMIDs 31517876, 35984870) that are double-blind, placebo-controlled designs investigating ashwagandha's effects on stress-related outcomes, which is c…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied. These are important distinctions because withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
The most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril, and these are important distinctions because withanolide content varies enormously across raw ashwagandha products.
The provided studies (PMIDs 34553463, 37878284, 37740662, 26609282, 32818573, 32540634, 31517876, and others) do include multiple RCTs using standardized ashwagandha extracts, which is consistent with…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided literature list includes multiple RCTs and a systematic review that are plausibly relevant to the claim (e.g., PMID 31517876 directly investigates stress-relieving actions of ashwagandha…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed approximately a 27% reduction in serum cortisol with ashwagandha.
The expert's claim specifically references the 2012 Chandrasekhar et al. study and a ~27% cortisol reduction figure, but this study does not appear among the 10 retrieved PubMed records provided for r…
“There are multiple double-blind placebo-controlled trials showing that KSM-66 supplementation at doses of 300 to 600 milligrams per day significantly reduces serum cortisol levels and reduces subjective measures of stress and anxiety.”
Multiple double-blind placebo-controlled trials show that KSM-66 at 300 to 600 milligrams per day significantly reduces serum cortisol levels and subjective measures of stress and anxiety.
The provided research list includes multiple RCTs and at least one systematic review on ashwagandha (Withania somnifera), including studies specifically examining stress, anxiety, and sleep outcomes (…
“there's some evidence that ashwagandha has mild sedative properties that make it slightly more useful taken in the evening”
There is some evidence that ashwagandha has mild sedative properties that make it slightly more useful when taken in the evening.
Several RCTs in the provided list (PMIDs 32818573 and 32540634) specifically investigated ashwagandha's effects on sleep quality, suggesting there is a recognized research basis for its sedative or sl…
“A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.”
A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.
The most relevant study in the provided list is PMID 26609282, an RCT titled 'Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial,…
“One of the most cited studies showed a 27% reduction in cortisol in the supplementation group versus placebo over 60 days.”
One of the most cited studies showed a 27% reduction in cortisol in the KSM-66 supplementation group versus placebo over 60 days.
The expert claims a specific 27% cortisol reduction associated with KSM-66 ashwagandha over 60 days, citing it as 'one of the most cited studies.' While several RCTs in the provided literature examine…
“there are a handful of studies showing that ashwagandha supplementation increases testosterone levels — roughly an 11 to 17% increase over placebo in some trials”
Studies show ashwagandha supplementation increases testosterone levels in men by roughly 11 to 17% over placebo.
None of the 10 provided studies report key findings related to testosterone levels in men, making it impossible to directly verify or contradict Huberman's specific claim of an 11–17% testosterone inc…
“The specific extracts that have the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.”
The specific ashwagandha extracts with the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.
The provided studies do include RCTs examining ashwagandha root extracts, and KSM-66 is indeed used in several of the listed trials (e.g., PMIDs 26609282, 32818573, 31517876), lending some support to…
“the standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day”
The standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day.
Several of the listed RCTs (e.g., PMIDs 26609282, 31517876, 32540634, 32818573, 33600918) are known to have used KSM-66 ashwagandha root extract at doses within the 300–600 mg/day range, which is broa…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population. I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
A handful of small trials show modest testosterone increases of 10 to 17% in men with ashwagandha, but most were conducted in infertile or sub-fertile men and are not generalizable to healthy men with normal baseline testosterone.
None of the 10 provided studies directly examine testosterone outcomes in men with ashwagandha supplementation. The retrieved literature focuses on perimenopause symptoms, stress relief, sleep quality…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7 in ashwagandha trials.
The claim that validated scales like the PSS (Perceived Stress Scale) and GAD-7 (Generalized Anxiety Disorder scale) showed improvement in ashwagandha trials is plausible given the studies listed, par…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses used in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, taken split or once daily for 8 to 12 weeks.
The published research includes multiple RCTs (PMIDs: 31517876, 32540634, 32818573, 26609282, 33600918, among others) that are consistent with the 300–600 mg standardized extract range and 8–12 week d…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population.”
A handful of trials show modest testosterone increases in men of approximately 10 to 17% with ashwagandha, but these studies are small and mostly conducted in infertile or sub-fertile men, limiting generalizability.
None of the 10 retrieved studies directly assess testosterone levels in men as a primary or secondary outcome. The provided studies focus on perimenopausal symptoms, stress, sleep quality, cardiorespi…
“One of the most cited studies showed a 27% reduction in cortisol in the supplementation group versus placebo over 60 days.”
One of the most cited studies showed a 27% reduction in cortisol in the KSM-66 supplementation group versus placebo over 60 days.
The provided research abstracts contain no extractable key findings, population details, or limitations data — all relevant fields are listed as 'None' — making it impossible to directly verify or ref…
“The specific extracts that have the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.”
The specific ashwagandha extracts with the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.
The provided studies include multiple RCTs investigating ashwagandha root extracts, and several PMIDs (e.g., 26609282, 31517876, 32540634, 32818573, 33600918) are known in the literature to use KSM-66…
“There's also reasonable evidence for muscle recovery and strength, independent of the testosterone effects.”
There is reasonable evidence for ashwagandha improving muscle recovery and strength, independent of its testosterone effects.
PMID 26609282 is a randomized controlled trial directly examining ashwagandha's effect on muscle strength and recovery, which is the most directly relevant study to this claim. PMID 33600918 also exam…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied.”
The two most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril.
The expert's claim is a descriptive statement about research methodology — specifically that KSM-66 and Sensoril are the two most commonly studied standardized ashwagandha extracts in clinical trials.…
“the standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day”
The standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day.
Several of the listed RCTs (e.g., PMIDs 26609282, 31517876, 32540634, 32818573, 33600918) are known in the literature to have used KSM-66 ashwagandha root extract at doses within the 300–600 mg/day ra…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim asserts that ashwagandha is the 'most clinically studied adaptogen' — a comparative statement requiring head-to-head data on the volume of clinical research across multiple adaptogens (e.g.,…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided literature includes multiple RCTs and a systematic review that appear relevant to ashwagandha's effects on stress-related outcomes (e.g., PMIDs 31517876, 38140274), which is consistent wi…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed approximately a 27% reduction in serum cortisol with ashwagandha.
The expert's claim specifically references the 2012 Chandrasekhar et al. RCT and its reported ~27% reduction in serum cortisol with ashwagandha. However, none of the 10 studies provided in the evidenc…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick considers the cortisol and stress/anxiety reduction effects of ashwagandha to be real, with meaningful effect sizes, replication, and biological plausibility.
Multiple RCTs in the provided list (e.g., PMIDs 31517876, 35984870) appear to directly address stress, anxiety, and cortisol outcomes with ashwagandha, and a systematic review (PMID 38140274, rated 's…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population. I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
A handful of small trials show modest testosterone increases of 10 to 17% in men with ashwagandha, but most were conducted in infertile or sub-fertile men and are not generalizable to healthy men with normal baseline testosterone.
None of the 10 provided studies directly address testosterone outcomes in men with ashwagandha supplementation. The retrieved literature focuses on perimenopause symptoms, cardiorespiratory endurance,…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.
The provided PubMed studies are consistent with ashwagandha RCTs that commonly use standardized root extracts in the 300–600 mg/day range over 8–12 week periods, which aligns with Rhonda Patrick's cla…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7 in ashwagandha trials.
The provided PubMed abstracts include several RCTs and a systematic review that appear relevant to ashwagandha's effects on stress and anxiety outcomes, and the broader literature does contain trials…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses used in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, taken split or once daily for 8 to 12 weeks.
The published research list includes multiple RCTs and a systematic review on ashwagandha supplementation (e.g., PMIDs 31517876, 32540634, 32818573, 26609282, 33600918, among others) that are consiste…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided research list includes multiple RCTs and a systematic review that are plausibly relevant to ashwagandha's effects on cortisol and stress (e.g., PMIDs 31517876, 37740662, 38140274), and th…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied. These are important distinctions because withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
The most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril, and these are important distinctions because withanolide content varies enormously across raw ashwagandha products.
The provided studies include several RCTs (e.g., PMIDs 26609282, 31517876, 32540634, 32818573) that do use standardized ashwagandha extracts in clinical trials, consistent with the claim that standard…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Ashwagandha improved subjective measures of stress and anxiety on validated scales including the PSS and the GAD-7 in clinical trials.
The provided literature list includes multiple RCTs on ashwagandha and stress-related outcomes (notably PMID 31517876, which directly investigates stress-relieving actions, and PMID 35984870, which ex…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population.”
A handful of trials show modest testosterone increases in men of approximately 10 to 17% with ashwagandha, but these studies are small and mostly conducted in infertile or sub-fertile men, limiting generalizability.
None of the 10 retrieved studies directly address testosterone levels in men with ashwagandha supplementation. The provided studies focus on perimenopausal symptoms, sleep quality, stress relief, card…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick considers the cortisol and stress/anxiety reduction effects of ashwagandha to be real, with meaningful effect sizes, replication, and biological plausibility.
The available literature includes a meta-analysis of RCTs (PMID: 36017529, rated strong quality) and at least two individual RCTs (PMIDs: 31517876, 35984870) specifically examining ashwagandha's effec…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick believes the cortisol-reducing and stress/anxiety effects of ashwagandha are real, with meaningful effect sizes, replication, and a biologically plausible mechanism.
The retrieved studies include multiple RCTs (e.g., PMIDs 31517876, 35984870) and a systematic review (PMID 38140274) that appear directly relevant to ashwagandha's stress, anxiety, and cortisol-reduci…
“One of the most cited studies showed a 27% reduction in cortisol in the supplementation group versus placebo over 60 days.”
One of the most cited studies showed a 27% reduction in cortisol in the KSM-66 supplementation group versus placebo over 60 days.
The provided PubMed abstracts do not contain extractable key findings, population details, or quantitative data, making it impossible to directly verify the specific claim of a 27% cortisol reduction…
“A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.”
A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.
PMID 26609282 is an RCT titled 'Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial,' which aligns closely with Huberman's claim a…
“There are multiple double-blind placebo-controlled trials showing that KSM-66 supplementation at doses of 300 to 600 milligrams per day significantly reduces serum cortisol levels and reduces subjective measures of stress and anxiety.”
Multiple double-blind placebo-controlled trials show that KSM-66 at 300 to 600 milligrams per day significantly reduces serum cortisol levels and subjective measures of stress and anxiety.
The provided studies include multiple double-blind, placebo-controlled RCTs on ashwagandha (Withania somnifera) extracts, and at least one study (PMID: 31517876) directly investigates stress-relieving…
“there are a handful of studies showing that ashwagandha supplementation increases testosterone levels — roughly an 11 to 17% increase over placebo in some trials”
Studies show ashwagandha supplementation increases testosterone levels in men by roughly 11 to 17% over placebo.
None of the 10 retrieved studies directly measure or report testosterone levels as a primary or secondary outcome in men. The studies focus on perimenopause symptoms, stress, sleep quality, cardioresp…
“there's some evidence that ashwagandha has mild sedative properties that make it slightly more useful taken in the evening”
There is some evidence that ashwagandha has mild sedative properties that make it slightly more useful when taken in the evening.
Several RCTs in the provided list (PMIDs 32818573 and 32540634) specifically investigated ashwagandha's effects on sleep quality, lending plausibility to the claim of mild sedative properties. However…
“The specific extracts that have the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.”
The specific ashwagandha extracts with the most research behind them are KSM-66 and Sensoril, both standardized extracts of the root.
None of the provided studies explicitly compare KSM-66 and Sensoril as the most-researched standardized ashwagandha extracts, nor do any of the listed publications contain extractable key findings tha…
“the standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day”
The standard dose used in most studies is 300 to 600 milligrams of KSM-66 extract per day.
The published research list provided includes relevant RCTs and reviews on ashwagandha (PMIDs 31517876, 37740662, 35984870) that could contain dosing information, but the key fields (key findings, pop…
“there are a handful of studies showing that ashwagandha supplementation increases testosterone levels — roughly an 11 to 17% increase over placebo in some trials”
Studies show ashwagandha supplementation increases testosterone levels in men by roughly 11 to 17% over placebo.
While the provided research list includes a systematic review on herbs and testosterone concentrations in men (PMID: 33150931) and several RCTs on ashwagandha, none of the studies include extractable…
“There's also reasonable evidence for muscle recovery and strength, independent of the testosterone effects.”
There is reasonable evidence for ashwagandha improving muscle recovery and strength, independent of its testosterone effects.
None of the 10 studies listed in the provided research base directly report key findings on muscle recovery or strength outcomes from ashwagandha supplementation. While some RCTs (PMIDs 31517876, 3774…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The published research list includes multiple RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) examining ashwagandha's effects on stress and anxiety, which are study types…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Ashwagandha improved subjective measures of stress and anxiety on validated scales including the PSS and the GAD-7 in clinical trials.
The published literature includes a meta-analysis of RCTs (PMID: 36017529, rated strong quality) and individual RCTs (PMIDs: 31517876, 37740662, 35984870) that are consistent with the expert's claim t…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim that ashwagandha is 'the most clinically studied adaptogen' is a comparative assertion about the volume of clinical research relative to other adaptogens, but none of the provided studies di…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied.”
The two most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril.
None of the provided studies include extractable key findings, populations, or limitations data, making it impossible to directly verify the claim from the listed research. While several of the cited…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The expert's claim specifically references the 2012 Chandrasekhar et al. study reporting a ~27% reduction in serum cortisol with ashwagandha. None of the 10 published research entries provided in the…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Ashwagandha improved subjective measures of stress and anxiety on validated scales including the PSS and the GAD-7 in clinical trials.
The available literature includes a meta-analysis (PMID: 36017529) and multiple RCTs (PMIDs: 31517876, 37740662, 35984870) that appear directly relevant to ashwagandha's effects on stress and anxiety,…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed approximately a 27% reduction in serum cortisol with ashwagandha.
The provided research list does not include the 2012 Chandrasekhar et al. study that the expert specifically references, nor do any of the listed studies provide key findings (all key findings are lis…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided research list includes multiple RCTs and a meta-analysis (PMID: 36017529, rated strong quality) examining ashwagandha's effects on stress and anxiety, along with individual RCTs (PMIDs: 3…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The provided research corpus includes multiple RCTs, meta-analyses, and systematic reviews involving ashwagandha (PMIDs 36017529, 35311615, 31517876, 37740662, 35984870), which collectively suggest as…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses used in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, taken split or once daily for 8 to 12 weeks.
The RCTs listed (PMIDs 31517876, 37740662, 35984870) are consistent with the claim that positive clinical trials have used ashwagandha in the 300–600 mg standardized extract range over 8–12 week perio…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied. These are important distinctions because withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
The most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril, and these are important distinctions because withanolide content varies enormously across raw ashwagandha products.
The provided research abstracts contain no extractable key findings, populations, or limitations data, making it impossible to directly verify the expert's claim from these citations. While several RC…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.
The referenced studies include RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) that examined ashwagandha supplementation, and the 300–600 mg standardized extract range an…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population.”
A handful of trials show modest testosterone increases in men of approximately 10 to 17% with ashwagandha, but these studies are small and mostly conducted in infertile or sub-fertile men, limiting generalizability.
The systematic review on herbs and testosterone concentrations in men (PMID: 33150931, strong quality) is the most directly relevant study in the provided list and likely covers the small RCTs on ashw…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided research list includes multiple RCTs and a meta-analysis (PMID: 36017529, 31517876, 37740662, 35984870) that are consistent with the general body of ashwagandha literature showing cortiso…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick believes the cortisol-reducing and stress/anxiety effects of ashwagandha are real, with meaningful effect sizes, replication, and a biologically plausible mechanism.
The available literature includes a meta-analysis (PMID: 36017529, rated strong quality) and multiple RCTs (PMIDs: 31517876, 37740662, 35984870) that are directly relevant to ashwagandha's effects on…
“One of the most cited studies showed a 27% reduction in cortisol in the supplementation group versus placebo over 60 days.”
One of the most cited studies showed a 27% reduction in cortisol in the KSM-66 supplementation group versus placebo over 60 days.
The published research list includes several RCTs and reviews on ashwagandha (including PMID 31517876, which is a randomized, double-blind, placebo-controlled study of ashwagandha extract and is among…
“there's some evidence that ashwagandha has mild sedative properties that make it slightly more useful taken in the evening”
There is some evidence that ashwagandha has mild sedative properties that make it slightly more useful when taken in the evening.
The published research provided contains no key findings, populations, or limitations data — all critical fields are listed as 'None' — making it impossible to directly evaluate the claim about ashwag…
“There are multiple double-blind placebo-controlled trials showing that KSM-66 supplementation at doses of 300 to 600 milligrams per day significantly reduces serum cortisol levels and reduces subjective measures of stress and anxiety.”
Multiple double-blind placebo-controlled trials show that KSM-66 at 300 to 600 milligrams per day significantly reduces serum cortisol levels and subjective measures of stress and anxiety.
The research database includes relevant study types (RCTs, meta-analyses, and systematic reviews on ashwagandha/Withania somnifera) that are consistent with the expert's claim, including PMID 36017529…
“A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.”
A study in resistance-trained men showed significantly greater gains in muscle size and strength in the ashwagandha group compared to placebo over 8 weeks.
None of the 10 listed studies directly investigate ashwagandha's effects on muscle size and strength in resistance-trained men. The available research covers anxiety/stress (PMID 36017529, 31517876, 3…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied.”
The two most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril.
The provided research abstracts contain no key findings, populations, or limitations data — they are essentially empty records — making it impossible to directly verify or contradict the claim that KS…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Ashwagandha improved subjective measures of stress and anxiety on validated scales including the PSS and the GAD-7 in clinical trials.
The published research list includes a meta-analysis (PMID: 36017529) specifically examining ashwagandha's effects on anxiety and stress, an RCT (PMID: 31517876) investigating stress-relieving actions…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population. I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
A handful of small trials show modest testosterone increases of 10 to 17% in men with ashwagandha, but most were conducted in infertile or sub-fertile men and are not generalizable to healthy men with normal baseline testosterone.
The expert's claim about modest testosterone increases (10-17%) in men using ashwagandha is plausible and aligns with the general body of ashwagandha research, and PMID 33150931 (a strong systematic r…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The provided research list does not include the 2012 Chandrasekhar et al. study that the expert specifically references, nor do any of the listed studies contain key findings, populations, or limitati…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7 in ashwagandha trials.
The available research corpus includes a meta-analysis (PMID: 36017529) and at least one RCT (PMID: 31517876) that are directly relevant to ashwagandha's effects on anxiety and stress, and these study…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol with ashwagandha.
The provided research list does not include the 2012 Chandrasekhar et al. study that the expert specifically references, nor do any of the listed studies report their key findings (all listed as 'None…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7 in ashwagandha trials.
The available studies include RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) that are consistent with examining validated stress and anxiety outcomes in ashwagandha tria…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick believes the cortisol-reducing and stress/anxiety effects of ashwagandha are real, with meaningful effect sizes, replication, and a biologically plausible mechanism.
The available literature includes a meta-analysis (PMID: 36017529, rated strong quality) and multiple RCTs (PMIDs: 31517876, 37740662, 35984870) that address ashwagandha's effects on stress and anxiet…
“I think this is real. The effect size is meaningful, replication exists, and the mechanism is biologically plausible.”
Patrick considers the cortisol and stress/anxiety reduction effects of ashwagandha to be real, with meaningful effect sizes, replication, and biological plausibility.
The available literature includes a meta-analysis of RCTs (PMID: 36017529), an RCT specifically examining stress-relieving actions (PMID: 31517876), and a college-student RCT on stress and sleep (PMID…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied. These are important distinctions because withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
The most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril, and these are important distinctions because withanolide content varies enormously across raw ashwagandha products.
The provided research abstracts contain no key findings, populations, or limitations data — they are essentially empty metadata records. None of the listed studies explicitly address the claim that KS…
“The best-controlled clinical studies have used standardized extracts — KSM-66 and Sensoril being the two most commonly studied.”
The two most commonly studied standardized ashwagandha extracts in clinical trials are KSM-66 and Sensoril.
The provided research abstracts contain no key findings, populations, or limitations data — they are essentially empty records. None of the listed studies explicitly confirm or deny that KSM-66 and Se…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.
The listed RCTs (PMIDs 31517876, 37740662, 35984870) and the meta-analysis (PMID 36017529) are consistent with the general claim that standardized ashwagandha extracts in the 300–600 mg/day range over…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population.”
A handful of trials show modest testosterone increases in men of approximately 10 to 17% with ashwagandha, but these studies are small and mostly conducted in infertile or sub-fertile men, limiting generalizability.
The systematic review (PMID: 33150931) on herbs and testosterone concentrations in men is the most directly relevant study in the provided literature and would likely address the testosterone findings…
“Doses in positive trials range from 300 to 600 milligrams of standardized extract per day, usually split or taken once daily for 8 to 12 weeks.”
Doses used in positive clinical trials range from 300 to 600 milligrams of standardized extract per day, taken split or once daily for 8 to 12 weeks.
The published research list includes multiple RCTs (PMIDs 31517876, 37740662, 35984870) and a meta-analysis (PMID 36017529) that have examined ashwagandha supplementation, and the dose range of 300–60…
“Multiple placebo-controlled trials show statistically significant reductions in cortisol”
Multiple placebo-controlled trials show statistically significant reductions in cortisol with ashwagandha.
The provided research list includes relevant study types (meta-analyses, RCTs, and systematic reviews on ashwagandha) that would be expected to address cortisol outcomes, including PMID 36017529 (meta…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population. I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
A handful of small trials show modest testosterone increases of 10 to 17% in men with ashwagandha, but most were conducted in infertile or sub-fertile men and are not generalizable to healthy men with normal baseline testosterone.
The systematic review on herbs and testosterone (PMID: 33150931) is the most directly relevant study in this list and would be expected to address the population specificity and effect size claims Rho…
“Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7.”
Subjective measures of stress and anxiety also improved on validated scales like the PSS and the GAD-7 in ashwagandha trials.
The available literature includes a meta-analysis (PMID: 36017529, rated strong quality) and multiple RCTs (PMIDs: 31517876, 37740662, 35984870) examining ashwagandha's effects on stress and anxiety,…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The provided research corpus contains several RCTs, meta-analyses, and reviews on ashwagandha's effects on anxiety, stress, cognition, testosterone, and safety, but none of the listed studies directly…
“one frequently cited 2012 study by Chandrasekhar et al. showed a roughly 27% reduction in serum cortisol”
A frequently cited 2012 study by Chandrasekhar et al. showed approximately a 27% reduction in serum cortisol with ashwagandha.
The expert references a specific 2012 Chandrasekhar et al. RCT reporting ~27% reduction in serum cortisol with ashwagandha. While this is a real and frequently cited study, that specific paper does no…
“Ashwagandha is probably the most clinically studied adaptogen”
Ashwagandha is the most clinically studied adaptogen.
The claim that ashwagandha is 'the most clinically studied adaptogen' is a comparative statement about the volume of research relative to other adaptogens, but none of the provided studies directly ad…
“There are a handful of trials showing modest testosterone increases in men — on the order of 10 to 17%. But these studies are small, and most of them are conducted in infertile or sub-fertile men, which is not a generalizable population. I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
A handful of small trials show modest testosterone increases of 10 to 17% in men with ashwagandha, but most were conducted in infertile or sub-fertile men and are not generalizable to healthy men with normal baseline testosterone.
The systematic review on herbs and testosterone (PMID: 33150931) is the most directly relevant study in this list and likely addresses the testosterone claims about ashwagandha in men, but no key find…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output, producing a modulatory, normalizing effect rather than a direct cortisol-blocking effect.
The published research provided contains no extractable key findings, populations, or limitations from any of the 10 studies listed—all relevant fields are null or empty. While the studies cited (e.g.…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output, producing a modulatory, normalizing effect rather than a direct cortisol-blocking effect.
The published research provided contains no extractable key findings, populations, or limitations — all those fields are listed as 'None' — making it impossible to directly evaluate the mechanistic cl…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a mechanistic one — specifically that withanolides modulate the HPA axis via the glucocorticoid receptor pathway. While the retrieved studies (RCTs, meta-analyses, and systematic…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The claim that ashwagandha contains withanolides that modulate the HPA axis via glucocorticoid receptor pathways has indirect support in the provided literature. The systematic review (PMID: 38140274)…
“The primary mechanism that's been studied is ashwagandha's effect on the HPA axis — the hypothalamic-pituitary-adrenal axis, which governs our cortisol stress response.”
Ashwagandha's primary studied mechanism is its effect on the HPA axis, which governs the cortisol stress response.
The provided studies include several RCTs investigating ashwagandha's effects on stress (e.g., PMID 31517876), sleep, athletic performance, and perimenopausal symptoms, but none of the retrieved abstr…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism of ashwagandha is that withanolides downregulate the stress-axis response, reducing excessive cortisol output — a modulatory, normalizing effect rather than direct cortisol blocking.
Several studies in the evidence base support the functional claim that ashwagandha reduces cortisol/stress-axis activity. The systematic review (PMID: 38140274) specifically assessed the impact of Wit…
“The primary mechanism that's been studied is ashwagandha's effect on the HPA axis — the hypothalamic-pituitary-adrenal axis, which governs our cortisol stress response.”
Ashwagandha's primary studied mechanism is its effect on the HPA axis, which governs the cortisol stress response.
While the provided studies (including RCTs such as PMID 31517876 and PMID 37740662, and a meta-analysis PMID 36017529) are relevant to ashwagandha's effects on stress and anxiety, none of the retrieve…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism of ashwagandha is that withanolides downregulate the stress-axis response, reducing excessive cortisol output — a modulatory, normalizing effect rather than direct cortisol blocking.
The expert's claim is a specific mechanistic assertion — that withanolides downregulate the HPA/stress-axis to modulate cortisol output rather than blocking it directly. While the provided literature…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
None of the 10 listed studies provide extractable key findings, populations, or limitations data, making it impossible to directly evaluate Patrick's mechanistic claim about ashwagandha's testosterone…
“The effect seems to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.”
The testosterone-increasing effect of ashwagandha appears to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.
None of the 10 provided studies contain extractable key findings, populations, or limitations data that would allow direct evaluation of the proposed cortisol-to-testosterone mechanistic pathway. The…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim is a specific mechanistic hypothesis—that ashwagandha raises testosterone indirectly by reducing cortisol, which otherwise suppresses LH and GnRH, and that this effect may be limite…
“cortisol is naturally higher in the morning — taking it at night may help modulate the evening cortisol levels that can disrupt sleep”
Taking ashwagandha at night may help modulate evening cortisol levels that can disrupt sleep, since cortisol is naturally higher in the morning.
The expert's claim is a mechanistic argument linking evening ashwagandha use to modulation of elevated evening cortisol that disrupts sleep. While several RCTs in the provided list (PMIDs 32818573, 32…
“The effect seems to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.”
The testosterone-increasing effect of ashwagandha appears to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.
The provided research abstracts contain no extractable key findings, populations, or limitations, making it impossible to directly evaluate Huberman's mechanistic claim that ashwagandha raises testost…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The provided research abstracts contain no extractable key findings, populations, or limitations — all critical fields are listed as 'None' — making it impossible to directly evaluate the mechanistic…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a mechanistic one — specifically that withanolides modulate the HPA axis via the glucocorticoid receptor pathway. None of the 10 provided studies report key findings, populations…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a mechanistic one — specifically that withanolides modulate the HPA axis via the glucocorticoid receptor pathway. The 10 provided studies are all clinical trials or systematic re…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a mechanistic assertion about withanolides modulating the HPA axis via the glucocorticoid receptor pathway. While the provided studies are RCTs and a systematic review examining…
“cortisol is naturally higher in the morning — taking it at night may help modulate the evening cortisol levels that can disrupt sleep”
Taking ashwagandha at night may help modulate evening cortisol levels that can disrupt sleep, since cortisol is naturally higher in the morning.
The expert's claim is a mechanistic argument linking evening ashwagandha use specifically to modulation of evening cortisol levels that disrupt sleep. While several RCTs in the provided list (PMIDs 32…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism of ashwagandha is that withanolides downregulate the stress-axis response, reducing excessive cortisol output — a modulatory, normalizing effect rather than direct cortisol blocking.
The expert's claim describes a specific mechanistic pathway — withanolides downregulating the HPA (stress-axis) response to normalize cortisol output rather than directly blocking it. While several of…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism of ashwagandha is that withanolides downregulate the stress-axis response, reducing excessive cortisol output — a modulatory, normalizing effect rather than direct cortisol blocking.
The expert's claim describes a specific mechanistic pathway — withanolides downregulating the HPA (stress-axis) response to modulate cortisol output — but none of the 10 provided studies contain extra…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output, producing a modulatory, normalizing effect rather than a direct cortisol-blocking effect.
The provided research corpus consists entirely of RCTs and one systematic review focused on clinical outcomes (stress, sleep, athletic performance, perimenopause), but none of the retrieved studies co…
“ashwagandha, which is one of the most studied adaptogens — meaning compounds that help the body adapt to stress”
Ashwagandha is one of the most studied adaptogens, meaning compounds that help the body adapt to stress.
The claim that ashwagandha is 'one of the most studied adaptogens' is broadly consistent with the volume of published research reflected in this literature set, which includes multiple RCTs, meta-anal…
“cortisol is naturally higher in the morning — taking it at night may help modulate the evening cortisol levels that can disrupt sleep”
Taking ashwagandha at night may help modulate evening cortisol levels that can disrupt sleep, since cortisol is naturally higher in the morning.
The expert's claim is a mechanistic discussion linking evening ashwagandha use to modulation of cortisol levels that could disrupt sleep. While the provided literature includes RCTs and meta-analyses…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim is a mechanistic hypothesis proposing that ashwagandha raises testosterone indirectly via cortisol suppression of LH and GnRH, and that effects may be limited to individuals with ch…
“The primary mechanism that's been studied is ashwagandha's effect on the HPA axis — the hypothalamic-pituitary-adrenal axis, which governs our cortisol stress response.”
Ashwagandha's primary studied mechanism is its effect on the HPA axis, which governs the cortisol stress response.
The expert's claim is a mechanistic statement about ashwagandha's primary studied mechanism involving the HPA axis and cortisol regulation. While the provided studies include an RCT (PMID: 31517876) e…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism of ashwagandha is that withanolides downregulate the stress-axis response, reducing excessive cortisol output — a modulatory, normalizing effect rather than direct cortisol blocking.
The provided research list includes relevant studies on ashwagandha (e.g., PMID 36017529 meta-analysis, PMID 31517876 RCT, PMID 37740662 RCT) that likely contain cortisol-related outcome data, but non…
“The effect seems to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.”
The testosterone-increasing effect of ashwagandha appears to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.
The provided research abstracts contain no extractable key findings, populations, or limitations — all relevant fields are null or incomplete — making it impossible to directly evaluate Huberman's mec…
“ashwagandha, which is one of the most studied adaptogens — meaning compounds that help the body adapt to stress”
Ashwagandha is one of the most studied adaptogens, meaning compounds that help the body adapt to stress.
The claim that ashwagandha is 'one of the most studied adaptogens' is broadly consistent with the volume of RCTs and systematic reviews in the provided literature (10 studies across stress, sleep, ath…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim is a mechanistic hypothesis proposing that ashwagandha raises testosterone indirectly by reducing cortisol, which in turn relieves suppression of LH and GnRH, with the effect potent…
“ashwagandha, which is one of the most studied adaptogens — meaning compounds that help the body adapt to stress”
Ashwagandha is one of the most studied adaptogens, meaning compounds that help the body adapt to stress.
The body of evidence provided, including multiple RCTs (PMIDs 31517876, 37740662, 35984870), a meta-analysis (PMID 36017529), and a systematic review on cortisol (PMID 38140274), collectively demonstr…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim proposes a specific mechanistic pathway (cortisol → LH/GnRH suppression → testosterone) and a conditional effect (only in individuals with genuinely elevated chronic cortisol). None…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a mechanistic assertion about withanolides modulating the HPA axis via the glucocorticoid receptor pathway. While the provided studies are largely RCTs examining clinical outcome…
“cortisol is naturally higher in the morning — taking it at night may help modulate the evening cortisol levels that can disrupt sleep”
Taking ashwagandha at night may help modulate evening cortisol levels that can disrupt sleep, since cortisol is naturally higher in the morning.
The available research corpus includes RCTs and reviews on ashwagandha's general stress-relieving and cortisol-modulating effects (e.g., PMIDs 31517876, 37740662, 35984870), but none of the provided s…
“The primary mechanism that's been studied is ashwagandha's effect on the HPA axis — the hypothalamic-pituitary-adrenal axis, which governs our cortisol stress response.”
Ashwagandha's primary studied mechanism is its effect on the HPA axis, which governs the cortisol stress response.
The published research provided includes relevant study types (RCTs, meta-analyses, systematic reviews) on ashwagandha, but none of the entries contain extractable key findings, populations, or limita…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim proposes a specific indirect mechanistic pathway (cortisol → LH/GnRH suppression → testosterone) and suggests effects may be limited to individuals with chronically elevated cortiso…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output, producing a modulatory, normalizing effect rather than a direct cortisol-blocking effect.
The provided research corpus consists entirely of RCTs and one systematic review evaluating clinical outcomes of ashwagandha supplementation (e.g., stress, sleep, athletic performance), but none of th…
“ashwagandha, which is one of the most studied adaptogens — meaning compounds that help the body adapt to stress”
Ashwagandha is one of the most studied adaptogens, meaning compounds that help the body adapt to stress.
The claim that ashwagandha is 'one of the most studied adaptogens' is broadly consistent with the volume of RCT and systematic review evidence provided (10 studies across stress, sleep, athletic perfo…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim is a mechanistic hypothesis about ashwagandha's testosterone effects being mediated through cortisol suppression of LH and GnRH, specific to individuals with chronic cortisol elevat…
“The effect seems to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.”
The testosterone-increasing effect of ashwagandha appears to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.
None of the 10 retrieved studies provide key findings, population details, or limitations in their metadata, making direct evaluation impossible from this evidence set. The expert's claim is a mechani…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The provided research abstracts contain no key findings, populations, or limitations data — all critical fields are listed as 'None' — making it impossible to directly assess Rhonda Patrick's mechanis…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output, producing a modulatory, normalizing effect rather than a direct cortisol-blocking effect.
The systematic review (PMID: 38140274) specifically assessed Withania somnifera's impact on cortisol levels, providing the most direct evidence for the modulatory cortisol mechanism Patrick describes.…
“ashwagandha, which is one of the most studied adaptogens — meaning compounds that help the body adapt to stress”
Ashwagandha is one of the most studied adaptogens, meaning compounds that help the body adapt to stress.
The claim that ashwagandha is one of the most studied adaptogens is broadly consistent with the volume of RCT and systematic review evidence provided (10 studies across stress, sleep, athletic perform…
“cortisol is naturally higher in the morning — taking it at night may help modulate the evening cortisol levels that can disrupt sleep”
Taking ashwagandha at night may help modulate evening cortisol levels that can disrupt sleep, since cortisol is naturally higher in the morning.
The expert's claim makes a specific mechanistic argument: that ashwagandha taken at night modulates elevated evening cortisol to improve sleep. While several RCTs in the provided list (PMIDs 32818573,…
“The primary mechanism that's been studied is ashwagandha's effect on the HPA axis — the hypothalamic-pituitary-adrenal axis, which governs our cortisol stress response.”
Ashwagandha's primary studied mechanism is its effect on the HPA axis, which governs the cortisol stress response.
The provided research abstracts contain no extractable key findings, populations, or limitations — all 10 studies list these fields as 'None' — making it impossible to directly evaluate the mechanisti…
“The effect seems to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.”
The testosterone-increasing effect of ashwagandha appears to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.
None of the 10 provided studies contain extractable key findings, populations, or limitations data, making it impossible to directly evaluate Huberman's mechanistic claim that ashwagandha raises testo…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a mechanistic assertion — that withanolides modulate the HPA axis via the glucocorticoid receptor pathway. While the provided studies include RCTs and reviews relevant to ashwaga…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output, producing a modulatory, normalizing effect rather than a direct cortisol-blocking effect.
The expert's claim describes a specific mechanistic pathway — withanolides downregulating the HPA (stress-axis) response to reduce excessive cortisol output in a modulatory rather than directly blocki…
“ashwagandha, which is one of the most studied adaptogens — meaning compounds that help the body adapt to stress”
Ashwagandha is one of the most studied adaptogens, meaning compounds that help the body adapt to stress.
The claim that ashwagandha is 'one of the most studied adaptogens' is directionally supported by the breadth of research present in this set, which includes at least one meta-analysis (PMID: 36017529)…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim proposes a specific mechanistic pathway — that ashwagandha raises testosterone indirectly by reducing cortisol, which in turn relieves suppression of LH and GnRH — and further specu…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism of ashwagandha is that withanolides downregulate the stress-axis response, reducing excessive cortisol output — a modulatory, normalizing effect rather than direct cortisol blocking.
The expert's claim describes a specific mechanistic pathway — withanolides downregulating the HPA (stress) axis to reduce excessive cortisol in a modulatory, normalizing fashion — but none of the 10 p…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a mechanistic one — that withanolides modulate the HPA axis via the glucocorticoid receptor pathway. While the provided studies include RCTs, meta-analyses, and reviews on ashwag…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim is a mechanistic hypothesis proposing that ashwagandha raises testosterone indirectly by suppressing cortisol, which in turn reduces cortisol-mediated inhibition of LH and GnRH, and…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output, producing a modulatory, normalizing effect rather than a direct cortisol-blocking effect.
The provided research list includes multiple RCTs and a systematic review on ashwagandha, but none of the entries contain extractable key findings, population details, or limitations — all critical fi…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output, producing a modulatory, normalizing effect rather than a direct cortisol-blocking effect.
The expert's claim describes a specific mechanistic pathway — withanolides downregulating the HPA (stress-axis) response to reduce excessive cortisol output in a modulatory rather than direct-blocking…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a specific mechanistic assertion — that withanolides modulate the HPA axis via the glucocorticoid receptor pathway. While the provided studies include RCTs and systematic reviews…
“The primary mechanism that's been studied is ashwagandha's effect on the HPA axis — the hypothalamic-pituitary-adrenal axis, which governs our cortisol stress response.”
Ashwagandha's primary studied mechanism is its effect on the HPA axis, which governs the cortisol stress response.
The systematic review (PMID: 38140274) specifically assessed the impact of Withania somnifera supplementation on cortisol levels, providing direct evidence that HPA axis modulation is a studied mechan…
“cortisol is naturally higher in the morning — taking it at night may help modulate the evening cortisol levels that can disrupt sleep”
Taking ashwagandha at night may help modulate evening cortisol levels that can disrupt sleep, since cortisol is naturally higher in the morning.
The claim has two components: (1) ashwagandha can modulate cortisol levels, and (2) taking it at night may specifically address evening cortisol disruption of sleep. The systematic review (PMID: 38140…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a mechanistic assertion about withanolides modulating the HPA axis via the glucocorticoid receptor pathway. While the 10 published studies provided are primarily RCTs examining c…
“The proposed mechanism is that withanolides can downregulate the stress-axis response, reducing excessive cortisol output. This is different from, say, a direct cortisol-blocking drug — it's more of a modulatory, normalizing effect, which is why the term 'adaptogen' is used.”
The proposed mechanism of ashwagandha is that withanolides downregulate the stress-axis response, reducing excessive cortisol output — a modulatory, normalizing effect rather than direct cortisol blocking.
The published research provided (10 RCTs and 1 systematic review) contains no extractable key findings, populations, or limitations — all relevant fields are null or empty. While several studies (e.g.…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim is a specific mechanistic hypothesis — that ashwagandha raises testosterone indirectly via cortisol suppression of the LH/GnRH axis, and that the effect may be limited to individual…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim is a mechanistic hypothesis proposing that ashwagandha raises testosterone indirectly by reducing cortisol, which in turn relieves suppression of LH and GnRH signaling, and that thi…
“The effect seems to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.”
The testosterone-increasing effect of ashwagandha appears to be mediated through cortisol reduction, since chronic high cortisol suppresses testosterone production via the HPG axis.
The provided studies do not directly test the mechanistic pathway claimed by Huberman — that ashwagandha raises testosterone specifically *because* it lowers cortisol via HPG axis disinhibition. While…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The expert's claim is a specific mechanistic hypothesis—that ashwagandha raises testosterone indirectly by reducing cortisol, which then relieves suppression of LH and GnRH, and that this effect is on…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The provided research abstracts contain no extractable key findings, populations, or limitations — all relevant fields are listed as 'None.' While the listed studies (including a meta-analysis, PMID 3…
“Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis — specifically by affecting the glucocorticoid receptor pathway.”
Ashwagandha contains bioactive compounds called withanolides, which appear to modulate the HPA axis by affecting the glucocorticoid receptor pathway.
The expert's claim is a mechanistic one — that withanolides modulate the HPA axis via the glucocorticoid receptor pathway. None of the 10 provided studies report key findings, populations, or limitati…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The provided research abstracts contain no extractable key findings, populations, or limitations data — only PMIDs and quality ratings — making it impossible to directly evaluate the mechanistic claim…
“The mechanism is also indirect — likely mediated through cortisol's suppression of LH and GnRH — which makes me think the testosterone effect may be real only in individuals with genuinely elevated chronic cortisol.”
The proposed mechanism for ashwagandha's testosterone effect is indirect, likely mediated through cortisol's suppression of LH and GnRH, suggesting the effect may only be real in individuals with genuinely elevated chronic cortisol.
The provided research abstracts contain no extractable key findings, populations, or limitations — all those fields are listed as 'None' — making it impossible to directly evaluate the mechanistic cla…
“I personally take 600 milligrams, typically at night”
Huberman personally takes 600 milligrams of ashwagandha, typically at night.
The claim is a personal anecdote about Huberman's own dosing practice (600 mg at night), not a scientific assertion about efficacy or optimal dosing. The published research provided includes multiple…
“I personally take 600 milligrams, typically at night”
Huberman personally takes 600 milligrams of ashwagandha, typically at night.
The claim is a personal anecdote about Huberman's individual supplementation practice (600 mg ashwagandha at night), which by definition cannot be directly supported or contradicted by published resea…
“I personally take 600 milligrams, typically at night”
Huberman personally takes 600 milligrams of ashwagandha, typically at night.
The claim is a personal anecdote about Huberman's own dosing regimen (600 mg ashwagandha at night) and cannot be directly evaluated against the published literature as a factual scientific claim. The…
“I personally take 600 milligrams, typically at night”
Huberman personally takes 600 milligrams of ashwagandha, typically at night.
The claim is a personal anecdote about Huberman's own dosing practice (600 mg at night), not a scientific assertion about efficacy or safety, so it cannot be directly supported or contradicted by clin…
“I personally take 600 milligrams, typically at night”
Huberman personally takes 600 milligrams of ashwagandha, typically at night.
The 600 mg dose Huberman describes aligns with doses used in several RCTs in the provided literature; for example, the Langade et al. (PMID: 32818573) sleep study and the Raut et al. safety study (PMI…
“I personally take 600 milligrams, typically at night”
Huberman personally takes 600 milligrams of ashwagandha, typically at night.
The claim is a personal anecdote about Huberman's own dosing behavior (600 mg at night), not a scientific claim about efficacy. The published research provided contains multiple RCTs on ashwagandha fo…
“The rationale is partly theoretical, but the concern is that sustained suppression of the HPA axis response could theoretically blunt adaptive stress responses. More research is needed on this.”
The rationale for cycling ashwagandha is partly theoretical: sustained suppression of the HPA axis could theoretically blunt adaptive stress responses, though more research is needed.
The expert's claim is a theoretical caution about sustained HPA axis suppression from cycling ashwagandha, and none of the 20 studies listed directly test this cycling rationale or measure adaptive st…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but safety signals warrant monitoring, particularly in people with pre-existing conditions.
The claim that ashwagandha is generally safe for most healthy adults at studied doses, with safety signals warranting monitoring, is broadly consistent with the available literature. The RCTs (PMIDs 3…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
The published research list includes a review specifically titled 'Ashwagandha-induced liver injury-A case series from India and literature review' (PMID: 37756041), which directly corresponds to the…
“Ashwagandha is in the nightshade family — people with nightshade sensitivities should be cautious.”
Ashwagandha is in the nightshade family, and people with nightshade sensitivities should be cautious.
The expert's claim is a botanical taxonomy fact — that ashwagandha (Withania somnifera) belongs to the Solanaceae (nightshade) family — paired with a precautionary note for people with nightshade sens…
“It's also a thyroid stimulant, so anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.”
Ashwagandha is a thyroid stimulant, and anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.
None of the 10 provided studies directly examine ashwagandha's effects on thyroid hormone levels, thyroid stimulation, or interactions with thyroid medication. The retrieved literature focuses on stre…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
None of the 10 provided PubMed studies address the taxonomic classification of ashwagandha (Withania somnifera) within the Solanaceae (nightshade) family, nor do any examine implications for autoimmun…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
The claim that ashwagandha (Withania somnifera) belongs to the nightshade family (Solanaceae) is a botanical fact that does not require clinical trial evidence to validate — it is taxonomically establ…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick urges caution regarding the testosterone data for ashwagandha and would not confidently extrapolate those findings to healthy men with normal baseline testosterone.
The systematic review on herbs and testosterone (PMID: 33150931) is the most directly relevant study in this set, and its strong quality rating suggests it examined the testosterone literature critica…
“Ashwagandha is in the nightshade family — people with nightshade sensitivities should be cautious.”
Ashwagandha is in the nightshade family, and people with nightshade sensitivities should be cautious.
None of the 10 provided studies address the botanical classification of ashwagandha (Withania somnifera) or its relationship to nightshade sensitivities. While ashwagandha is indeed a member of the So…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but safety signals warrant monitoring, particularly in people with pre-existing conditions.
The claim that ashwagandha is generally safe for most healthy adults at studied doses, while warranting monitoring for those with pre-existing conditions, is directionally consistent with the availabl…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick urges caution regarding the testosterone data for ashwagandha and would not confidently extrapolate those findings to healthy men with normal baseline testosterone.
The provided research list includes one systematic review specifically examining herbs and testosterone concentrations in men (PMID: 33150931), which is directly relevant to Patrick's claim, but no ke…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick would not confidently extrapolate ashwagandha's testosterone findings to healthy men with normal baseline testosterone.
None of the 10 provided studies contain extractable key findings, population details, or limitations data, making it impossible to directly evaluate Patrick's cautious position on ashwagandha's testos…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
The published research list includes a review specifically titled 'Ashwagandha-induced liver injury-A case series from India and literature review' (PMID: 37756041), which directly aligns with the exp…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but the safety signals warrant monitoring, particularly in people with pre-existing conditions.
The available literature includes a case series on ashwagandha-induced liver injury (PMID: 37756041) and multiple RCTs and systematic reviews examining efficacy and safety at studied doses (PMIDs: 360…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
None of the 10 provided studies directly address hepatotoxicity associated with ashwagandha. The retrieved literature consists entirely of RCTs focused on efficacy outcomes (sleep, stress, athletic pe…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 published research abstracts provided contain key findings, populations, or limitations data relevant to ashwagandha's thyroid-stimulating properties or effects on T3/T4 levels. The ret…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 published studies retrieved address thyroid hormone levels (T3/T4) or thyroid-related outcomes. The studies focus on stress relief, sleep quality, athletic performance, muscle strength,…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 published studies listed in the evidence base directly address ashwagandha's effects on thyroid hormones (T3/T4) or its interactions with levothyroxine. The available research covers an…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
The expert's claim is directly supported by two studies in the evidence base. PMID 37756041, a case series review from India described as the 'first and currently largest' series of ashwagandha-induce…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
None of the 10 provided studies address the taxonomic classification of ashwagandha (Withania somnifera) as a member of the Solanaceae (nightshade) family, nor do any examine its relevance for individ…
“Ashwagandha is in the nightshade family — people with nightshade sensitivities should be cautious.”
Ashwagandha is in the nightshade family, and people with nightshade sensitivities should be cautious.
None of the 10 provided studies address the botanical classification of ashwagandha (Withania somnifera) or its relationship to the nightshade family (Solanaceae), nor do any examine cross-reactivity…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but safety signals warrant monitoring, particularly in people with pre-existing conditions.
Multiple lines of evidence support the expert's claim. The RCT by Pratte et al. (PMID: 33338583) directly evaluated safety and tolerability in healthy volunteers and found ashwagandha to be generally…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
The expert's claim is directly supported by PMID 37756041, a review specifically titled 'Ashwagandha-induced liver injury—A case series from India and literature review,' which explicitly documents ca…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick would not confidently extrapolate ashwagandha's testosterone findings to healthy men with normal baseline testosterone.
The systematic review on herbs and testosterone (PMID: 33150931) and the RCTs on ashwagandha (PMIDs: 31517876, 37740662) are the most relevant studies here, but none of the provided records include ke…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
None of the 10 provided studies address the taxonomic classification of ashwagandha (Withania somnifera) as a member of the Solanaceae (nightshade) family, nor do any examine its relevance for individ…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
None of the 10 published studies provided address the botanical classification of ashwagandha (Withania somnifera) as a member of the Solanaceae (nightshade) family or its implications for individuals…
“It's also a thyroid stimulant, so anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.”
Ashwagandha is a thyroid stimulant, and anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.
None of the 10 provided studies directly investigated ashwagandha's effects on thyroid hormone levels, thyroid stimulation, or safety in populations with thyroid conditions or on thyroid medication. T…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick urges caution regarding the testosterone data for ashwagandha and would not confidently extrapolate those findings to healthy men with normal baseline testosterone.
The provided research abstracts contain no extractable key findings, population data, or limitations — all critical fields are null. While PMID 33150931 (a systematic review on herbs and testosterone…
“The rationale is partly theoretical, but the concern is that sustained suppression of the HPA axis response could theoretically blunt adaptive stress responses. More research is needed on this.”
The rationale for cycling ashwagandha is partly theoretical: sustained suppression of the HPA axis could theoretically blunt adaptive stress responses, though more research is needed.
The expert's claim is explicitly theoretical — that sustained HPA axis suppression from ashwagandha could blunt adaptive stress responses — and no study in the provided list directly tests or addresse…
“withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
Withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in clinical trials.
None of the 10 published studies provided contain extractable key findings, populations, or limitations data, making it impossible to directly evaluate Rhonda Patrick's claim about withanolide variabi…
“these studies are not enormous, and the testosterone increase is modest, but it is directionally consistent across studies”
The studies on ashwagandha and testosterone are not large, and the testosterone increase is modest, but directionally consistent across studies.
The expert's claim that ashwagandha studies on testosterone are small, show modest but directionally consistent increases, is a cautious and nuanced characterization that aligns with the general scien…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick would not confidently extrapolate ashwagandha's testosterone findings to healthy men with normal baseline testosterone.
None of the 10 provided studies directly address testosterone outcomes in healthy men with normal baseline testosterone levels, which is the specific population Patrick's caution concerns. The studies…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
None of the 10 published studies provided in the evidence base address hepatotoxicity or liver-related adverse events associated with ashwagandha supplementation. The retrieved literature consists ent…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
None of the 10 provided studies contain extractable key findings relevant to hepatotoxicity or liver safety signals associated with ashwagandha. The retrieved literature consists primarily of RCTs foc…
“withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
Withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in clinical trials.
The expert's claim concerns withanolide variability across raw ashwagandha products and the non-comparability of unstandardized preparations to clinical trial formulations. While several RCTs in the p…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
The published research list includes a review specifically titled 'Ashwagandha-induced liver injury-A case series from India and literature review' (PMID: 37756041), which aligns directly with the exp…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
None of the 10 provided studies address the taxonomic classification of ashwagandha (Withania somnifera) or its relevance to nightshade-sensitive individuals with autoimmune conditions. The studies fo…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
The expert's claim is a botanical/taxonomic fact — Withania somnifera (ashwagandha) does belong to the Solanaceae (nightshade) family — combined with a practical caution for people with autoimmune con…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
The expert's claim is directly supported by the published literature available. PMID 37756041 is explicitly a review of ashwagandha-induced liver injury presenting a case series from India alongside a…
“withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
Withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in clinical trials.
The expert's claim is biologically and pharmacologically plausible and aligns with general principles of herbal standardization, but the provided studies do not directly measure or report on variabili…
“withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
Withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in clinical trials.
None of the provided studies contain extractable key findings, populations, or limitations data, making direct comparison impossible. While the expert's claim about withanolide variability across unst…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
The expert's claim is directly supported by the published literature. PMID 37756041, a review specifically titled 'Ashwagandha-induced liver injury-A case series from India and literature review,' exp…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick would not confidently extrapolate ashwagandha's testosterone findings to healthy men with normal baseline testosterone.
The provided research abstracts contain no extractable key findings, populations, or limitations — all relevant fields are null or empty. While PMID 33150931 (a strong systematic review on herbs and t…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 published studies retrieved directly address ashwagandha's effects on thyroid hormones (T3/T4) or its relevance for subclinical hyperthyroidism or levothyroxine interactions. The studie…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick would not confidently extrapolate ashwagandha's testosterone findings to healthy men with normal baseline testosterone.
Patrick's caution about extrapolating ashwagandha's testosterone findings to healthy men with normal baseline testosterone is scientifically reasonable and aligns with general principles of evidence-b…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 published studies retrieved address thyroid hormone levels (T3/T4) or thyroid-stimulating effects of ashwagandha. The studies focus on perimenopause, stress, sleep, athletic performance…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 published studies in the provided list directly address ashwagandha's effects on thyroid hormones (T3/T4) or its interactions with levothyroxine. The available literature covers anxiety…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick urges caution regarding the testosterone data for ashwagandha and would not confidently extrapolate those findings to healthy men with normal baseline testosterone.
None of the 10 provided studies directly examine testosterone outcomes in healthy men with normal baseline testosterone levels, which is the precise population and outcome Patrick's caution addresses.…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but the safety signals warrant monitoring, particularly in people with pre-existing conditions.
The claim that ashwagandha is generally safe for most healthy adults at studied doses, while warranting caution in those with pre-existing conditions, is partially supported by the available evidence.…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
None of the 10 provided studies address hepatotoxicity or liver-related adverse events associated with ashwagandha; their key findings, populations, and limitations fields are unpopulated, precluding…
“The rationale is partly theoretical, but the concern is that sustained suppression of the HPA axis response could theoretically blunt adaptive stress responses. More research is needed on this.”
The rationale for cycling ashwagandha is partly theoretical: sustained suppression of the HPA axis could theoretically blunt adaptive stress responses, though more research is needed.
Huberman's claim is explicitly theoretical — that sustained HPA axis suppression from ashwagandha could blunt adaptive stress responses — and none of the 10 published studies provided contain key find…
“Ashwagandha is in the nightshade family — people with nightshade sensitivities should be cautious.”
Ashwagandha is in the nightshade family, and people with nightshade sensitivities should be cautious.
The expert's claim is a botanical classification statement — that ashwagandha (Withania somnifera) belongs to the Solanaceae (nightshade) family — which is factually accurate per plant taxonomy, but n…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but the safety signals warrant monitoring, particularly in people with pre-existing conditions.
The expert's claim that ashwagandha is generally safe at studied doses while warranting monitoring aligns with the general direction of the available literature. The inclusion of a case series review…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but safety signals warrant monitoring, particularly in people with pre-existing conditions.
The provided studies are all RCTs or systematic reviews examining ashwagandha in various healthy adult populations (stress, sleep, athletic performance, perimenopause), which is consistent with the cl…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but the safety signals warrant monitoring, particularly in people with pre-existing conditions.
Multiple lines of evidence support this nuanced claim. The RCT by Pratte et al. (PMID 31517876) and the sleep RCTs (PMIDs 32818573, 32540634) demonstrated acceptable safety profiles in healthy adults…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 published studies provided in the evidence base examined thyroid hormone levels (T3/T4) or thyroid-related outcomes, making it impossible to directly evaluate the expert's claim from th…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 provided studies directly address ashwagandha's effects on thyroid hormones (T3/T4) or its interactions with levothyroxine. The available literature covers anxiety/stress, cognition, te…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
The expert's claim is a botanical/taxonomic statement — that ashwagandha (Withania somnifera) belongs to the Solanaceae (nightshade) family — with a downstream caution for autoimmune patients managing…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but the safety signals warrant monitoring, particularly in people with pre-existing conditions.
The 10 studies provided (primarily moderate-quality RCTs) do not contain extractable key findings, populations, or limitations in the structured data, making it impossible to directly evaluate safety…
“It's also a thyroid stimulant, so anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.”
Ashwagandha is a thyroid stimulant, and anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.
None of the 10 published studies provided contain extractable key findings, populations, or limitations relevant to ashwagandha's effects on thyroid function or its safety in individuals with thyroid…
“It's also a thyroid stimulant, so anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.”
Ashwagandha is a thyroid stimulant, and anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.
None of the 20 published research sources provided directly address ashwagandha's effects on thyroid function, thyroid stimulation, or interactions with thyroid medications. While some studies (e.g.,…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick would not confidently extrapolate ashwagandha's testosterone findings to healthy men with normal baseline testosterone.
The provided research abstracts contain no extractable key findings, population details, or limitations — rendering direct comparison impossible. While PMID 33150931 (a strong systematic review on her…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 provided PubMed studies address ashwagandha's effects on thyroid hormones (T3/T4) or its relevance to subclinical hyperthyroidism or levothyroxine interactions. The retrieved literature…
“generic ashwagandha powder of unknown withanolide content is not the same thing”
Generic ashwagandha powder of unknown withanolide content is not the same as the standardized extracts studied in research.
The expert's caution is conceptually well-grounded: all 10 RCTs in the provided evidence base explicitly used standardized or characterized ashwagandha extracts (as indicated by titles referencing 'ro…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
None of the 10 provided studies directly address hepatotoxicity or liver-related adverse events associated with ashwagandha supplementation. The available literature consists entirely of RCTs focused…
“The rationale is partly theoretical, but the concern is that sustained suppression of the HPA axis response could theoretically blunt adaptive stress responses. More research is needed on this.”
The rationale for cycling ashwagandha is partly theoretical: sustained suppression of the HPA axis could theoretically blunt adaptive stress responses, though more research is needed.
The expert's claim is explicitly theoretical in nature, asserting that sustained HPA axis suppression from ashwagandha could blunt adaptive stress responses — and acknowledges more research is needed.…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
The published research list includes a review specifically titled 'Ashwagandha-induced liver injury-A case series from India and literature review' (PMID: 37756041), which directly aligns with the exp…
“generic ashwagandha powder of unknown withanolide content is not the same thing”
Generic ashwagandha powder of unknown withanolide content is not the same as the standardized extracts studied in research.
The research base consistently uses standardized ashwagandha extracts with defined withanolide concentrations (e.g., the RCTs by PMIDs 31517876, 26609282, 32818573, 32540634 all specify standardized r…
“generic ashwagandha powder of unknown withanolide content is not the same thing”
Generic ashwagandha powder of unknown withanolide content is not the same as the standardized extracts studied in research.
The expert's claim is biologically and methodologically plausible: multiple RCTs in the provided list (PMIDs 31517876, 37740662, 35984870) explicitly used standardized ashwagandha extracts with define…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but safety signals warrant monitoring, particularly in people with pre-existing conditions.
The 10 published studies provided (9 RCTs and 1 systematic review) contain no extractable key findings, population details, or limitations data, making it impossible to directly assess the safety prof…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 retrieved studies directly address ashwagandha's effects on thyroid hormones (T3/T4) or its relevance to subclinical hyperthyroidism or levothyroxine interactions. The retrieved literat…
“The rationale is partly theoretical, but the concern is that sustained suppression of the HPA axis response could theoretically blunt adaptive stress responses. More research is needed on this.”
The rationale for cycling ashwagandha is partly theoretical: sustained suppression of the HPA axis could theoretically blunt adaptive stress responses, though more research is needed.
The expert's claim is explicitly framed as theoretical — that cycling ashwagandha may prevent blunting of adaptive HPA axis stress responses — and acknowledges more research is needed. None of the 10…
“withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
Withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in clinical trials.
The expert's claim that withanolide content varies across raw ashwagandha products and that unstandardized preparations cannot be compared to clinical trials is biologically plausible and consistent w…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
The expert's claim that Ashwagandha (Withania somnifera) belongs to the nightshade family (Solanaceae) is botanically accurate — this is confirmed incidentally in Study 15, which identifies WS as 'a p…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
The claim made by Rhonda Patrick is a botanical/taxonomic claim — that ashwagandha (Withania somnifera) belongs to the Solanaceae (nightshade) family — with an implied clinical caution for people with…
“generic ashwagandha powder of unknown withanolide content is not the same thing”
Generic ashwagandha powder of unknown withanolide content is not the same as the standardized extracts studied in research.
The expert's claim is grounded in a sound principle of pharmacognosy and is implicitly supported by the research corpus provided: every RCT and systematic review in the list explicitly used standardiz…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick would not confidently extrapolate ashwagandha's testosterone findings to healthy men with normal baseline testosterone.
None of the 10 provided studies contain extractable key findings, populations, or limitations data, making it impossible to directly assess Patrick's cautionary claim about extrapolating ashwagandha t…
“these studies are not enormous, and the testosterone increase is modest, but it is directionally consistent across studies”
The studies on ashwagandha and testosterone are not large, and the testosterone increase is modest, but directionally consistent across studies.
None of the 10 provided studies report key findings, populations, or limitations in their metadata, making it impossible to directly verify Huberman's claim about modest, directionally consistent test…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 published studies provided in this dataset directly examine ashwagandha's effects on thyroid hormones (T3 or T4), thyroid-stimulating properties, or interactions with levothyroxine. The…
“withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
Withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in clinical trials.
The expert's claim about withanolide variability and the incomparability of unstandardized preparations to clinical trial formulations is biologically plausible and consistent with general phytochemic…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick urges caution regarding the testosterone data for ashwagandha and would not confidently extrapolate those findings to healthy men with normal baseline testosterone.
Patrick's caution about extrapolating testosterone findings to healthy men with normal baseline testosterone is partially supported by the available evidence. The systematic review on herbs and testos…
“these studies are not enormous, and the testosterone increase is modest, but it is directionally consistent across studies”
The studies on ashwagandha and testosterone are not large, and the testosterone increase is modest, but directionally consistent across studies.
The systematic review on herbs and testosterone (PMID: 33150931) is the most directly relevant study and supports the directional consistency Huberman describes, while the RCT on ashwagandha and muscl…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick urges caution regarding the testosterone data for ashwagandha and would not confidently extrapolate those findings to healthy men with normal baseline testosterone.
None of the 10 provided studies specifically examine testosterone outcomes in healthy men with normal baseline testosterone levels, which is the precise population and endpoint referenced in Patrick's…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
The expert's claim is a botanical/taxonomic fact — Withania somnifera (ashwagandha) is indeed a member of the Solanaceae (nightshade) family — combined with a clinical caution for autoimmune patients…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but safety signals warrant monitoring, particularly in people with pre-existing conditions.
The available literature provides partial support for this claim. The meta-analysis (PMID: 36017529) and RCTs (PMIDs: 31517876, 37740662, 35984870) generally evaluate ashwagandha at studied doses in h…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but safety signals warrant monitoring, particularly in people with pre-existing conditions.
The 10 studies provided (predominantly moderate-quality RCTs) generally tested ashwagandha in healthy adults across domains such as stress, sleep, athletic performance, and perimenopausal symptoms, wh…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
The expert's claim is a botanical/taxonomic fact — Withania somnifera (ashwagandha) is indeed a member of the Solanaceae (nightshade) family — combined with a practical caution for people managing aut…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 provided studies directly investigated ashwagandha's effects on thyroid hormones (T3/T4) or examined populations with subclinical hyperthyroidism or levothyroxine use. The retrieved lit…
“Ashwagandha has thyroid-stimulating properties — a few case reports and one small study suggest it can elevate T3 and T4 levels. For someone with subclinical hyperthyroidism or on levothyroxine, this could be clinically relevant.”
Ashwagandha has thyroid-stimulating properties; a few case reports and one small study suggest it can elevate T3 and T4 levels, which could be clinically relevant for people with subclinical hyperthyroidism or those on levothyroxine.
None of the 10 published studies provided contain key findings, populations, or limitations data that can be used to directly evaluate the claim about ashwagandha's thyroid-stimulating properties or i…
“generic ashwagandha powder of unknown withanolide content is not the same thing”
Generic ashwagandha powder of unknown withanolide content is not the same as the standardized extracts studied in research.
The claim is logically sound and consistent with standard pharmacological principles: the published RCTs listed (PMIDs 31517876, 32540634, 32818573, 26609282, 33600918, etc.) consistently used standar…
“these studies are not enormous, and the testosterone increase is modest, but it is directionally consistent across studies”
The studies on ashwagandha and testosterone are not large, and the testosterone increase is modest, but directionally consistent across studies.
The provided research abstracts do not contain key findings, population details, or limitations data, making it impossible to directly verify or contradict Huberman's claim about modest, directionally…
“The rationale is partly theoretical, but the concern is that sustained suppression of the HPA axis response could theoretically blunt adaptive stress responses. More research is needed on this.”
The rationale for cycling ashwagandha is partly theoretical: sustained suppression of the HPA axis could theoretically blunt adaptive stress responses, though more research is needed.
The expert's claim is a theoretical caution about prolonged HPA axis suppression from ashwagandha potentially blunting adaptive stress responses, explicitly framed as speculative. None of the 10 publi…
“It's also a thyroid stimulant, so anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.”
Ashwagandha is a thyroid stimulant, and anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.
None of the 10 provided studies contain extractable key findings relevant to ashwagandha's effects on thyroid function or its interactions with thyroid medication. While ashwagandha has been studied i…
“Ashwagandha is in the nightshade family — people with nightshade sensitivities should be cautious.”
Ashwagandha is in the nightshade family, and people with nightshade sensitivities should be cautious.
The claim that ashwagandha (Withania somnifera) belongs to the Solanaceae (nightshade) family is botanically accurate — this is established taxonomic fact, not a research finding that requires RCT val…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but the safety signals warrant monitoring, particularly in people with pre-existing conditions.
The 10 studies provided (mostly moderate-quality RCTs) cover ashwagandha's effects on stress, sleep, athletic performance, and perimenopausal symptoms, but none of the provided records include extract…
“There have also been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though these are rare and causality is unclear.”
There have been rare but documented case reports of hepatotoxicity associated with ashwagandha supplements, though causality is unclear.
None of the 10 provided studies address hepatotoxicity or liver-related adverse events associated with ashwagandha supplementation. The retrieved literature consists entirely of RCTs focused on effica…
“generic ashwagandha powder of unknown withanolide content is not the same thing”
Generic ashwagandha powder of unknown withanolide content is not the same as the standardized extracts studied in research.
The expert's claim is biologically and methodologically plausible: the RCTs provided (e.g., PMIDs 31517876 and 37740662) specifically used standardized ashwagandha extracts with defined withanolide co…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick urges caution regarding the testosterone data for ashwagandha and would not confidently extrapolate those findings to healthy men with normal baseline testosterone.
None of the 10 provided studies directly address testosterone outcomes in healthy men with normal baseline testosterone levels following ashwagandha supplementation. The retrieved literature focuses o…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
None of the 10 studies listed in the published research directly address the botanical classification of ashwagandha (Withania somnifera) as a member of the Solanaceae (nightshade) family, nor do any…
“these studies are not enormous, and the testosterone increase is modest, but it is directionally consistent across studies”
The studies on ashwagandha and testosterone are not large, and the testosterone increase is modest, but directionally consistent across studies.
The provided research abstracts do not contain extractable key findings, populations, or limitations data relevant to testosterone outcomes, making it impossible to directly verify or refute the exper…
“withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
Withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in clinical trials.
The expert's claim about variability in withanolide content and the non-comparability of unstandardized preparations is pharmacologically plausible and consistent with the fact that virtually all RCTs…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
None of the 10 listed studies address the botanical classification of ashwagandha (Withania somnifera) or its relevance to nightshade-sensitive or autoimmune populations. While ashwagandha is indeed a…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but the safety signals warrant monitoring, particularly in people with pre-existing conditions.
The expert's claim that ashwagandha is generally safe for healthy adults at studied doses while warranting monitoring—especially for those with pre-existing conditions—is partially supported by the av…
“withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in trials.”
Withanolide content varies enormously across raw ashwagandha products, and unstandardized preparations cannot be compared to what was used in clinical trials.
The provided research abstracts contain no extractable key findings, populations, or limitations data, making direct comparison impossible. While several RCTs in the list (PMIDs 31517876, 37740662, 35…
“It's also a thyroid stimulant, so anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.”
Ashwagandha is a thyroid stimulant, and anyone on thyroid medication or with existing thyroid conditions should consult their physician before using it.
None of the 10 provided studies contain extractable findings (key findings, populations, and limitations are all listed as 'None'), making it impossible to directly evaluate Huberman's claim that ashw…
“ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.”
Ashwagandha is in the nightshade family, which may be relevant for people with autoimmune conditions who are managing nightshade intake.
None of the 10 published research entries provided address the botanical classification of ashwagandha (Withania somnifera) as a member of the Solanaceae (nightshade) family, nor do any examine implic…
“Ashwagandha is in the nightshade family — people with nightshade sensitivities should be cautious.”
Ashwagandha is in the nightshade family, and people with nightshade sensitivities should be cautious.
The claim that Ashwagandha (Withania somnifera) belongs to the Solanaceae (nightshade) family is botanically accurate and is corroborated by the systematic review (PMID: 38140274), which explicitly id…
“these studies are not enormous, and the testosterone increase is modest, but it is directionally consistent across studies”
The studies on ashwagandha and testosterone are not large, and the testosterone increase is modest, but directionally consistent across studies.
The expert's claim that ashwagandha studies on testosterone are small, show modest but directionally consistent increases, is a cautious and generally well-regarded characterization in the literature.…
“I think the compound is generally safe for most healthy adults at studied doses, but these signals warrant monitoring, particularly in people with pre-existing conditions.”
Ashwagandha is generally safe for most healthy adults at studied doses, but the safety signals warrant monitoring, particularly in people with pre-existing conditions.
The 10 studies listed (predominantly moderate-quality RCTs across populations including healthy adults, athletes, college students, and perimenopausal women, plus one strong systematic review) are con…
“I would not confidently extrapolate those testosterone findings to healthy men with normal baseline testosterone.”
Patrick urges caution regarding the testosterone data for ashwagandha and would not confidently extrapolate those findings to healthy men with normal baseline testosterone.
The systematic review (PMID: 33150931) on herbs and testosterone concentrations in men is the most directly relevant study, but its key findings are not populated in the provided records, limiting dir…